Antigenicity of fullerenes: antibodies specific for fullerenes and their characteristics.
about
Development and characterization of antibody reagents for detecting nanoparticlesHuman health implications of nanomaterial exposureNanotoxicology: an emerging discipline evolving from studies of ultrafine particlesImmunomodulation of nanoparticles in nanomedicine applicationsChemical basis of interactions between engineered nanoparticles and biological systemsX-ray crystal structure of an anti-Buckminsterfullerene antibody Fab fragment: Biomolecular recognition of C60Engineered metal based nanoparticles and innate immunityFullerene-biomolecule conjugates and their biomedicinal applications.Respiratory toxicity and immunotoxicity evaluations of microparticle and nanoparticle C60 fullerene aggregates in mice and rats following nose-only inhalation for 13 weeksEffect of fullerenol surface chemistry on nanoparticle binding-induced protein misfolding.Applications of functionalized fullerenes in tumor theranostics.Molecular dynamics analysis of a buckyball-antibody complex.Formation of a soluble stable complex between pristine C60-fullerene and a native blood protein.Analytical strategies for detecting nanoparticle-protein interactions.Nanoparticles and the immune systemFullerene-based amino acids and peptides.In vitro toxicity assessment of three hydroxylated fullerenes in human skin cells.Rosette Nanotubes Alter IgE-Mediated Degranulation in the Rat Basophilic Leukemia (RBL)-2H3 Cell Line.What else can the immune system recognize?Carbon nanotubes for the delivery of therapeutic molecules.In vivo studies of fullerene-based materials using endohedral metallofullerene radiotracers.Understanding the immunogenicity and antigenicity of nanomaterials: Past, present and future.Protein-directed self-assembly of a fullerene crystal.Macrophage scavenger receptor A mediates the uptake of gold colloids by macrophages in vitro.The biological mechanisms and physicochemical characteristics responsible for driving fullerene toxicity.Protein bio-corona: critical issue in immune nanotoxicology.Challenges in development of nanoparticle-based therapeutics.Fullerene derivatives protect against oxidative stress in RAW 264.7 cells and ischemia-reperfused lungs.Study on the antigenicity of metallofullerenol: antibody production, characterization, and its enzyme immunoassay application.Fullerenes in Biology and Medicine.In vitro action of carboxyfullerene.A multiple gadolinium complex decorated fullerene as a highly sensitive T(1) contrast agent.Assessment of interactions of efavirenz solid drug nanoparticles with human immunological and haematological systems.Pharmacokinetics and Toxicology of the Neuroprotective e,e,e-Methanofullerene(60)-63-tris Malonic Acid [C3] in Mice and Primates.Biomedical nanoparticles modulate specific CD4+ T cell stimulation by inhibition of antigen processing in dendritic cells.Determining the relationship between nanoparticle characteristics and immunotoxicity: key challenges and approaches.Fullerene sorting proteinsExploring the Inhibitory and Antioxidant Effects of Fullerene and Fullerenol on Ribonuclease AAn Electrochemical Immunosensor for Fullerenol Detection Based on the Generated AntibodyApplications of Anti/Prooxidant Fullerenes in Nanomedicine along with Fullerenes Influence on the Immune System
P2860
Q23921977-F512DAD7-DBD9-46CE-B2FE-4798346AC4E9Q23922473-BAEC7B34-A9AC-4024-83C5-6BB8C7D99228Q24536032-EA4B191C-1B9F-4FCD-AEE3-12EEC8C388F5Q27021145-D176F983-7CE1-4B47-BB90-96433A661CA8Q27021154-827F4D17-4D93-46CD-BE2B-C18D86DBD643Q27627507-49E657E3-E467-45B3-9924-CBC93FB8699FQ28383470-AA86A548-973B-4E42-A1BA-C751A7C85E83Q28393292-B0B99DE6-5B8B-4EEF-89AB-07A983B9590CQ28397732-57A6E96D-10A5-4806-AADF-EC3FB93991A0Q30363665-AB41339A-4E61-4928-95B2-EB908F9C7CD7Q30468506-C629D17F-7601-4FC3-AC13-F2CB7B72CFF6Q30476373-98783D86-D5ED-48B8-86F2-8FBFDF46031CQ33255280-38E33C51-2C0A-4A2C-A156-3D6C2B69A53CQ33587673-124C575B-A8EB-475F-B40D-CFE954314A37Q33634320-E4AF7FA1-F582-430C-93D5-103786570D6EQ34251777-383EA401-A450-4344-9A45-855AA6A4EB8EQ35552477-5E7B3D02-6F5D-4B50-ACF3-5170894796C6Q35725010-A2F22D98-AD09-401B-B50B-7AF869982C11Q36076975-E3557C6D-49A8-4462-875C-399711CB8800Q36316616-96C9DFF5-F21F-4B8B-A513-44A4AB2EA710Q36339544-6910C2C9-E35D-4AF8-8F5D-F6D5C47E9B65Q36739647-3B916218-7813-4DFB-B6C1-15AB4F7B5BBDQ36859160-C1EA9481-B6F1-4127-8167-1A09CE57CA3FQ37549974-BEB51588-5BBD-4810-890E-5E353E2B6DE7Q37630089-B3DF558C-5B8E-4F5D-BCF1-2081D94743F4Q37651354-BCE90825-2BFD-447C-AAF7-A4367A6C2374Q37992525-0F414F82-C073-4FAB-81C7-BBF5C4301CE8Q40546803-B3C5A7B9-75BE-4728-8348-18A326120282Q49908646-00127C6D-1022-439C-855B-018C27DD8066Q49960476-9A0A1371-24C4-4990-B00A-AE12CB7D7581Q50110473-DDEB0F32-21B0-4DB0-8CB2-71578A5A80DFQ51008833-8B26406C-7B13-46CA-8727-4A931F8BB897Q51739696-DCACE951-0442-4002-A410-9A7A4E87F497Q51764649-29414FFF-8F37-4427-AF05-45A205B79111Q53275631-03876621-9AA6-4EC8-8278-0A66D729BE6EQ53755427-1794AA1C-F738-42AB-92F9-F7B4FC159A12Q56985375-81DDA369-5DFC-48DD-B447-2922EE4FF9D4Q57489563-2DC33658-2083-405F-AE2D-6B8E86997DCAQ58272110-7C542FE3-6F27-4D6A-97A3-5CF346E9B890Q59113625-9999CAA0-C3F3-469B-9328-70B1C55CC69D
P2860
Antigenicity of fullerenes: antibodies specific for fullerenes and their characteristics.
description
1998 nî lūn-bûn
@nan
1998 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Antigenicity of fullerenes: antibodies specific for fullerenes and their characteristics.
@ast
Antigenicity of fullerenes: antibodies specific for fullerenes and their characteristics.
@en
Antigenicity of fullerenes: antibodies specific for fullerenes and their characteristics.
@nl
type
label
Antigenicity of fullerenes: antibodies specific for fullerenes and their characteristics.
@ast
Antigenicity of fullerenes: antibodies specific for fullerenes and their characteristics.
@en
Antigenicity of fullerenes: antibodies specific for fullerenes and their characteristics.
@nl
prefLabel
Antigenicity of fullerenes: antibodies specific for fullerenes and their characteristics.
@ast
Antigenicity of fullerenes: antibodies specific for fullerenes and their characteristics.
@en
Antigenicity of fullerenes: antibodies specific for fullerenes and their characteristics.
@nl
P2093
P2860
P356
P1476
Antigenicity of fullerenes: antibodies specific for fullerenes and their characteristics.
@en
P2093
P2860
P304
10809-10813
P356
10.1073/PNAS.95.18.10809
P407
P577
1998-09-01T00:00:00Z